Minimal improvements in the global burden of skin disease from 1990 to 2013 - 18/04/17
Doi : 10.1016/j.jaad.2016.08.006
Jessica Mounessa a, Taylor Braunberger, MD b, Cory A. Dunnick, MD a, d, Robert P. Dellavalle, MD, PhD, MSPH a, c, d, ⁎ 
a Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado
b University of North Dakota School of Medicine, Fargo, North Dakota
c Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado
d Dermatology Service, Eastern Colorado Health Care System, US Department of Veteran Affairs, Denver, Colorado
∗Correspondence to: Robert P. Dellavalle, MD, PhD, MSPH, Chief, Dermatology Service, Department of Veteran Affairs Medical Center, 1055 Clermont St, Box 165, Denver, CO 80220Dermatology ServiceDepartment of Veteran Affairs Medical Center1055 Clermont St, Box 165DenverCO80220
| Ms Mounessa and Dr Braunberger contributed equally to this article. |
|
| Funding sources: The Bill and Melinda Gates Foundation. |
|
| Conflicts of interest: None declared. |
© 2016
Publié par Elsevier Masson SAS.
Vol 76 - N° 1
P. 148 - janvier 2017 Retour au numéro
Article précédent
- The effect of climate change on skin disease in North America
- Benjamin H. Kaffenberger, David Shetlar, Scott A. Norton, Misha Rosenbach
- A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo
- Stefan G. Vanderweil, Shinya Amano, Wei-Che Ko, Jillian M. Richmond, Michelle Kelley, Maryanne Makredes Senna, Andrea Pearson, Sandhya Chowdary, Celia Hartigan, Bruce Barton, John E. Harris
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?